The authors reply

Affiliations

¹ Division of Digestive Health and Liver Diseases, Miller School of Medicine, University of Miami, Miami, Florida, USA.
² Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. Electronic address: michel.jadoul@uclouvain.be.

Free article

Comment

Paul Martin et al. Kidney Int. 2020 Mar.

Free article

. 2020 Mar;97(3):615.

doi: 10.1016/j.kint.2019.11.033.

¹ Division of Digestive Health and Liver Diseases, Miller School of Medicine, University of Miami, Miami, Florida, USA.
² Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. Electronic address: michel.jadoul@uclouvain.be.

No abstract available

Comment on

Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and management.
Jadoul M, Berenguer MC, Doss W, Fabrizi F, Izopet J, Jha V, Kamar N, Kasiske BL, Lai CL, Morales JM, Patel PR, Pol S, Silva MO, Balk EM, Gordon CE, Earley A, Di M, Martin P. Jadoul M, et al. Kidney Int. 2018 Oct;94(4):663-673. doi: 10.1016/j.kint.2018.06.011. Kidney Int. 2018. PMID: 30243313
Daclatasvir plus asunaprevir in the treatment of uremic patients with chronic hepatitis C genotype 1b infection.
Huang CF, Yu ML. Huang CF, et al. Kidney Int. 2020 Mar;97(3):615. doi: 10.1016/j.kint.2019.10.033. Kidney Int. 2020. PMID: 32087891 No abstract available.